vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Claritev Corp (CTEV). Click either name above to swap in a different company.
Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -32.7%, a 40.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 6.2%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $36.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 2.5%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
COLL vs CTEV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $246.6M |
| Net Profit | $17.0M | $-80.6M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | -3.1% |
| Net Margin | 8.3% | -32.7% |
| Revenue YoY | 12.9% | 6.2% |
| Net Profit YoY | 35.3% | 41.6% |
| EPS (diluted) | $0.48 | $-4.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $246.6M | ||
| Q3 25 | $209.4M | $246.0M | ||
| Q2 25 | $188.0M | $241.6M | ||
| Q1 25 | $177.8M | $231.3M | ||
| Q4 24 | $181.9M | $232.1M | ||
| Q3 24 | $159.3M | $230.5M | ||
| Q2 24 | $145.3M | $233.5M | ||
| Q1 24 | $144.9M | $234.5M |
| Q4 25 | $17.0M | $-80.6M | ||
| Q3 25 | $31.5M | $-69.8M | ||
| Q2 25 | $12.0M | $-62.6M | ||
| Q1 25 | $2.4M | $-71.3M | ||
| Q4 24 | $12.5M | $-138.0M | ||
| Q3 24 | $9.3M | $-391.4M | ||
| Q2 24 | $19.6M | $-576.7M | ||
| Q1 24 | $27.7M | $-539.7M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | -3.1% | ||
| Q3 25 | 29.7% | 4.1% | ||
| Q2 25 | 18.7% | 6.9% | ||
| Q1 25 | 12.2% | 4.2% | ||
| Q4 24 | 20.9% | -17.8% | ||
| Q3 24 | 21.9% | -146.7% | ||
| Q2 24 | 32.7% | -224.4% | ||
| Q1 24 | 34.1% | -207.4% |
| Q4 25 | 8.3% | -32.7% | ||
| Q3 25 | 15.0% | -28.4% | ||
| Q2 25 | 6.4% | -25.9% | ||
| Q1 25 | 1.4% | -30.8% | ||
| Q4 24 | 6.9% | -59.4% | ||
| Q3 24 | 5.9% | -169.8% | ||
| Q2 24 | 13.5% | -247.0% | ||
| Q1 24 | 19.1% | -230.1% |
| Q4 25 | $0.48 | $-4.88 | ||
| Q3 25 | $0.84 | $-4.23 | ||
| Q2 25 | $0.34 | $-3.81 | ||
| Q1 25 | $0.07 | $-4.38 | ||
| Q4 24 | $0.36 | $-8.49 | ||
| Q3 24 | $0.27 | $-24.25 | ||
| Q2 24 | $0.52 | $-35.78 | ||
| Q1 24 | $0.71 | $-33.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $16.8M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $301.7M | $-173.9M |
| Total Assets | $1.7B | $4.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $16.8M | ||
| Q3 25 | $285.9M | $39.2M | ||
| Q2 25 | $222.2M | $56.4M | ||
| Q1 25 | $197.8M | $23.1M | ||
| Q4 24 | $162.8M | $16.8M | ||
| Q3 24 | $120.0M | $86.6M | ||
| Q2 24 | $271.6M | $48.8M | ||
| Q1 24 | $318.0M | $58.7M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $301.7M | $-173.9M | ||
| Q3 25 | $274.8M | $-101.8M | ||
| Q2 25 | $232.2M | $-39.9M | ||
| Q1 25 | $234.4M | $14.8M | ||
| Q4 24 | $228.8M | $84.0M | ||
| Q3 24 | $234.3M | $207.6M | ||
| Q2 24 | $216.6M | $603.4M | ||
| Q1 24 | $222.2M | $1.2B |
| Q4 25 | $1.7B | $4.9B | ||
| Q3 25 | $1.6B | $5.0B | ||
| Q2 25 | $1.6B | $5.1B | ||
| Q1 25 | $1.6B | $5.1B | ||
| Q4 24 | $1.7B | $5.2B | ||
| Q3 24 | $1.6B | $5.3B | ||
| Q2 24 | $1.1B | $5.7B | ||
| Q1 24 | $1.1B | $6.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 304.87× | ||
| Q4 24 | — | 53.67× | ||
| Q3 24 | — | 21.73× | ||
| Q2 24 | — | 7.48× | ||
| Q1 24 | — | 3.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $66.3M |
| Free Cash FlowOCF − Capex | $122.4M | $36.4M |
| FCF MarginFCF / Revenue | 59.6% | 14.8% |
| Capex IntensityCapex / Revenue | 0.3% | 12.1% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $66.3M | ||
| Q3 25 | $78.4M | $19.9M | ||
| Q2 25 | $72.4M | $61.2M | ||
| Q1 25 | $55.4M | $-30.1M | ||
| Q4 24 | $84.6M | $-33.4M | ||
| Q3 24 | $-9.0M | $72.8M | ||
| Q2 24 | $67.4M | $18.5M | ||
| Q1 24 | $61.9M | $49.7M |
| Q4 25 | $122.4M | $36.4M | ||
| Q3 25 | $78.3M | $-16.3M | ||
| Q2 25 | $72.4M | $36.6M | ||
| Q1 25 | $54.6M | $-68.9M | ||
| Q4 24 | $84.1M | $-63.8M | ||
| Q3 24 | $-9.2M | $41.1M | ||
| Q2 24 | $67.1M | $-7.0M | ||
| Q1 24 | $61.4M | $19.2M |
| Q4 25 | 59.6% | 14.8% | ||
| Q3 25 | 37.4% | -6.6% | ||
| Q2 25 | 38.5% | 15.2% | ||
| Q1 25 | 30.7% | -29.8% | ||
| Q4 24 | 46.2% | -27.5% | ||
| Q3 24 | -5.8% | 17.8% | ||
| Q2 24 | 46.2% | -3.0% | ||
| Q1 24 | 42.3% | 8.2% |
| Q4 25 | 0.3% | 12.1% | ||
| Q3 25 | 0.1% | 14.7% | ||
| Q2 25 | 0.0% | 10.2% | ||
| Q1 25 | 0.4% | 16.8% | ||
| Q4 24 | 0.3% | 13.1% | ||
| Q3 24 | 0.2% | 13.8% | ||
| Q2 24 | 0.2% | 10.9% | ||
| Q1 24 | 0.4% | 13.0% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
